Companies / Turkey

Reforms Have Refreshed Drug Market

July 2007 | Industry News

Printable version
Bookmark

Although reforms enacted over the past five years have greatly improved the operating environment of the Turkish drug market,

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

IMF Warns Over Health Spending

Companies / Turkey The International Monetary Fund (IMF) has warned Turkey over its health spending, which it claims has risen dramatically from 3.7% of GDP in 1999 to 5% in 2005. This is now allegedly higher than in...

November 2006

Actavis Launching New Generics

Companies / Turkey Icelandic drugmaker Actavis has launched three new generic drugs in Turkey, as the company continues to expand in the country. The three products include Xetanor (paroxetine), an antidepressant in SSRI...

October 2006

Roche Compensates Government

Companies / Turkey Swiss drugmaker Roche has paid compensation of EUR1.4mn (US$1.76mn) to the Turkish Health Ministry after allegedly causing the government to incur substantial losses by overcharging for drugs. However,...

October 2006

Turkey's Abdi Ibrahim, India's Strides Agree Alliance

Companies / Turkey Indian generics firm Strides has agreed a joint venture with Turkish drugmaker Abdi Ibrahim to sell its products in Turkey and in neighbouring countries. The Turkish drug market is currently worth around...

June 2006

Interest In Selcuk Ecza Surges

Companies / Turkey Turkish drug distributor Selcuk Ecza has seen demand for shares soar after its US$180mn offering for a 20% stake in the company. According to reports, the IPO was 9.65 times oversubscribed. The company...

May 2006